Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis

PÜRNAK T., Efe C., KAV T., Wahlin S., Ozaslan E.

DIGESTIVE DISEASES AND SCIENCES, cilt.62, sa.10, ss.2900-2907, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 62 Sayı: 10
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1007/s10620-017-4728-2
  • Dergi Adı: DIGESTIVE DISEASES AND SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2900-2907
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Beyond available guidelines, therapy of autoimmune hepatitis (AIH) shows wide variation among physicians. We compared two regimens for treatment naive AIH: one recommended protocol with an initial prednisolone dose of 30 mg/day and our own 40 mg/day prednisolone with a slow dose tapering protocol. We analyzed the safety, response rates, and outcomes for two groups of treated patients.